The Impact of Penicillin Allergy
Arlington Heights, USA
DURATION
0 up to 1 Days
LANGUAGES
English
PACE
Full time
APPLICATION DEADLINE
Request application deadline
EARLIEST START DATE
Sep 2023
TUITION FEES
Request tuition fees
STUDY FORMAT
On-Campus
Scholarships
Explore scholarship opportunities to help fund your studies
Introduction
Viewers can earn credit by completing the post-test questions
This program is a collaboration between the American College of Allergy, Asthma and Immunology and the Allergy and Asthma Network.
There is no commercial support for this activity.
Target Audience
Primary Care Providers
Fellows-in-Training
Upon completion of this activity, learners should be able to:
Describe the implications of the penicillin allergy label
Understand approaches for de-labelling
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide medical education for physicians.
As required by the Accreditation Council for Continuing Medical Education (ACCME) and following the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. The ACCME defines a "commercial interest" as any entity producing, marketing, re-selling, distributing health care goods or services used on, or consumed by, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners before the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.